IFNγ modulates human immunoglobulin receptor expression in lipoaspirate-derived mesenchymal stem cells

Dian R. Laksmitawati, Jeanne A. Pawitan, Mohamad Sadikin, Caroline T. Sardjono, Ahmad R. Utomo

DOI: https://doi.org/10.13181/mji.v23i3.923


Background: Mesenchymal stem cell (MSC) has been reported to have immunomodulator capacity against autoimmune diseases and to prevent allogenic tissue rejection. Many studies revealed that MSC’s inhibit T cell proliferation and induce immunosuppressive condition through the production of prostaglandins, and interleukin-10. In addition, MSC was reported to reduce circulating autoantibody in autoimmune patients following MSC transfusion. So far, there has been no report stating the presence of Fc receptors (receptors for immunoglobulin) on MSCs. The aim of this study was to reveal the expression of FcγRs in lipoaspirate-derived MSCs by measuring transcription of FcγR mRNA and whether the expression can be modulated.

Methods: Lipoaspirate-derived MSCs were cultured in suitable medium and confirmed to be MSCs according to the criteria published by International Society for Cellular Therapy. Total mRNA of MSCs was isolated, and detection of human FcγRI, FcγRIIA and FcγRIIB mRNA was performed. Further, modulation of the expression was tested using heat aggregated gamma globulin (HAGG) and interferon (IFN)γ.

Results: FcγRs mRNA was detected in the first passage of MSCs. However, the expression was no longer present after more than 4 passages. Further, increased level of FcγRI and FcγRIIA mRNA expression was detected with the addition of IFNγ in the culture. This preliminary finding opens a new insight for the understanding of interaction between MSCs and immunoglobulin G through FcγRs.

Conclusion: Lipoaspirate-derived MSCs express FcγRs, and the expression is modulated by IFNγ.


Fcγ receptor; interferon γ; immunoglobulin G; mesenchymal stem cell

Full Text:



  1. Ringdén O, Uzunel M, Sundberg B, Lönnies L, Nava S, Gustafsson J, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia. 2007;21(11):2271-6. http://dx.doi.org/10.1038/sj.leu.2404833
  2. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294-301. http://dx.doi.org/10.1634/stemcells.2005-0342
  3. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-28. http://dx.doi.org/10.1089/107632701300062859
  4. Sardjono CT, Setiawan M, Frisca, Saputra V, Aniko G, Sandra F. Application of a modified method for stem cell isolation from lipoaspirates in a basic lab. Med J Indones. 2009;18(2):91-6. http://dx.doi.org/10.13181/mji.v18i2.343
  5. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. http://dx.doi.org/10.1080/14653240600855905
  6. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99(10):3838-43. http://dx.doi.org/10.1182/blood.V99.10.3838
  7. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815-22. http://dx.doi.org/10.1182/blood-2004-04-1559
  8. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007;109(1):228-34. http://dx.doi.org/10.1182/blood-2006-02-002246
  9. Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103(12):4619-21. http://dx.doi.org/10.1182/blood-2003-11-3909
  10. Laksmitawati D, Sardjono C, Pawitan J, Sadikin M, Sandra F. Secretion of Indoleamine 2,3-Dioxygenase, An Immunomodulatory Substance, By Adipose-Derived Mesenchymal Stem Cell. Indonesian Journal of Cancer Chemoprevention. 2010;1(2):92-8.
  11. Li Y, Lee PY, Kellner ES, Paulus M, Switanek J, Xu Y, et al. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(3):R90. http://dx.doi.org/10.1186/ar3017
  12. Quan Y, Moller T, Weinstein JR. Regulation of Fcgamma receptors and immunoglobulin G-mediated phagocytosis in mouse microglia. Neurosci Lett. 2009;464(1):29-33. http://dx.doi.org/10.1016/j.neulet.2009.08.013

Copyright (c) 2014 Dian R. Laksmitawati, Jeanne A. Pawitan, Mohamad Sadikin, Caroline T. Sardjono, Ahmad R. Utomo

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles and issues in Medical Journal of Indonesia have unique DOI number registered in Crossref.